Zorzetti Noemi, Marino Ignazio Roberto, Sorrenti Salvatore, Navarra Giuseppe Giovanni, D'Andrea Vito, Lauro Augusto
General Surgery, Ospedale Civile "A. Costa", Alto Reno Terme, Bologna, Italy.
Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy.
Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec;17(7):677-690. doi: 10.1080/17474124.2023.2221433. Epub 2023 Jun 5.
Advances in the management of intestinal failure have led to a reduction in the number of intestinal transplants. The number of bowel transplants has been mainly stable even though a slight increase has been observed in the last 5 years.
Standard indication includes patients with a reasonable life expectancy. Recent progress can be deduced by the increased number of intestine transplants in adults: this is due to the continuous improvement of 1-year graft survival worldwide (without differences in 3- and 5-year) associated with better abdominal wall closure techniques. This review aims to provide an update on new indications and changes in trends of pediatric and adult intestine transplantation. This analysis, which stretches through the past 5 years, is based on a collection of related manuscripts from PubMed.
Intestinal transplants should be solely intended for a group of individuals for whom indications for transplantation are clear and both medical and surgical rehabilitations have failed. Nevertheless, many protocols developed over the years have not yet solved the key question represented by the over-immunosuppression. Novel indications and recent progress in the bowel transplant field, minimal yet consistent, represent a pathway to be followed.
肠道衰竭管理方面的进展已导致肠道移植数量减少。尽管在过去5年中观察到肠道移植数量略有增加,但肠道移植数量总体上一直保持稳定。
标准适应症包括预期寿命合理的患者。成人肠道移植数量的增加可推断出近期的进展:这归因于全球范围内1年移植物存活率的持续提高(3年和5年存活率无差异)以及更好的腹壁闭合技术。本综述旨在提供儿科和成人肠道移植新适应症及趋势变化的最新情况。这项贯穿过去5年的分析基于从PubMed收集的相关手稿。
肠道移植应仅针对移植适应症明确且内科和外科康复均失败的特定人群。然而,多年来制定的许多方案尚未解决过度免疫抑制这一关键问题。肠道移植领域的新适应症和近期进展虽微小但持续,是一条值得遵循的途径。